Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Moxifloxacin (0.3% w/v) Eye Ointment
Therapeutic Category
Antibiotic, Ophthalmology, Antibacterials
Dosage Form
Eye Ointment
Packaging Type
Tube
Packaging
5gm
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Moxolunic Mini Eye Ointment containing Moxifloxacin is used for the management of bacterial eye infections. It helps control susceptible bacterial pathogens and supports effective treatment of ocular infections.
Moxifloxacin works as a fluoroquinolone antibiotic by inhibiting bacterial DNA gyrase and topoisomerase IV, helping eliminate susceptible bacteria responsible for eye infections and promoting recovery of affected ocular tissues.
The eye ointment is widely prescribed in ophthalmology practice for bacterial ocular infections and post-procedural infection prevention, leading to consistent prescription demand.
With the increasing prevalence of eye infections and growing demand for advanced ophthalmic antibiotics, this product offers strong business potential for retailers and distributors. Its established antibacterial efficacy, broad-spectrum coverage, and steady market demand make it a reliable product for growth in the ophthalmology segment.
Common side effects may include temporary blurred vision, mild stinging or burning sensation, redness, or eye irritation after application. Rarely, hypersensitivity reactions may occur.
Moxolunic Mini Eye Ointment is indicated for the treatment of bacterial conjunctivitis, keratitis, blepharitis, and other superficial ocular infections caused by susceptible Gram-positive and Gram-negative bacteria.
Use Moxolunic Mini Eye Ointment strictly under the guidance of an ophthalmologist. Avoid touching the tube tip to the eye or any surface to prevent contamination. Complete the full prescribed course even if symptoms improve. Discontinue use and consult a doctor if severe irritation or allergic reactions occur.
Store in a cool, dry place below 25°C. Protect from direct sunlight, keep the tube tightly closed, and out of reach of children. Do not use beyond the expiry date.
Composition : Carboxymethylcellulose (1% w/v) + Oxychloro Complex (0.0075% w/v)
Composition : Carboxymethylcellulose (3mg/ml) + Glycerin (10mg/ml) + n-acetylcarnosine (10mg/ml)
Composition : Dexamethasone (0.1% w/v) + Tobramycin (0.3% w/v)
Composition : Fluconazole (0.3% w/v)
Composition : Flurbiprofen (0.03% w/v) + Gatifloxacin (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
Composition : Ketorolac (0.4% w/v) + Olopatadine (0.1% w/v)
Composition : Ketorolac (0.5% w/v)
Composition : Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Moxifloxacin 0.5% w/v Eye Ointment has strong demand in the ophthalmology, anti-infective, and eye care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on advanced ocular healthcare portfolios.
Medical distributors and agencies can benefit from consistent demand for bacterial eye infection management under medical supervision. Moxifloxacin 0.5% w/v is a fourth-generation fluoroquinolone antibiotic with broad-spectrum antibacterial activity Commonly prescribed for bacterial conjunctivitis, blepharitis, keratitis, corneal ulcers, and other susceptible bacterial eye infections Helps inhibit bacterial growth and supports effective management of ocular infections Ointment formulation provides prolonged contact with the ocular surface, enhancing therapeutic effectiveness Frequently used in pre-operative and post-operative eye care to help reduce the risk of bacterial infections as advised by ophthalmologists Widely prescribed by ophthalmologists and eye care specialists This strengthens a comprehensive ophthalmology and anti-infective portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Moxifloxacin 0.5% w/v Eye Ointment with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong demand in ophthalmology clinics, hospitals, and eye care centers, repeat prescriptions, reliable supply chain support, and attractive margins in the ophthalmic anti-infective segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.